Literature DB >> 1596598

Clinical trials and clinical practice in the elderly. A focus on hypertension.

M E Kitler1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1596598     DOI： 10.2165/00002512-199202020-00002

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  61 in total

1.  The quality of life, research, and care.

Authors:  R A Deyo
Journal:  Ann Intern Med       Date:  1991-04-15       Impact factor: 25.391

2.  Confidence intervals for reporting results of clinical trials.

Authors:  R Simon
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

3.  Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels.

Authors:  F H Messerli; K Sundgaard-Riise; H O Ventura; F G Dunn; L B Glade; E D Frohlich
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

4.  The neglected time factor and antihypertensive therapy. A pitfall in evaluating side effects in a cross-over study.

Authors:  D Edmonds; P Greminger; W Vetter; P Baumgart; H Vetter
Journal:  Postgrad Med       Date:  1988-02-29       Impact factor: 3.840

5.  The recent decline in ischemic heart disease mortality.

Authors:  M P Stern
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

Review 6.  Should the elderly hypertensive be treated? Evidence from clinical trials.

Authors:  R A Davidson; G J Caranasos
Journal:  Arch Intern Med       Date:  1987-11

7.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

8.  How physicians choose drugs.

Authors:  P Denig; F M Haaijer-Ruskamp; D H Zijsling
Journal:  Soc Sci Med       Date:  1988       Impact factor: 4.634

Review 9.  Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine.

Authors:  K Anastos; P Charney; R A Charon; E Cohen; C Y Jones; C Marte; D M Swiderski; M E Wheat; S Williams
Journal:  Ann Intern Med       Date:  1991-08-15       Impact factor: 25.391

10.  The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?

Authors:  L Farnett; C D Mulrow; W D Linn; C R Lucey; M R Tuley
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272
View more
  2 in total

Review 1.  Optimising the economic efficiency of drug studies.

Authors:  M E Kitler
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

Review 2.  Optimising treatment of elderly patients with ovarian cancer : improving their enrollment in clinical trials.

Authors:  Jeannine Villella; Eva Chalas
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.